14.1 Why invest in Wellspring
- Defensive, structurally growing category: Wellness and preventative-health spending is resilient and compounding, giving downside protection with structural upside.
- Private-label margin engine: Scaling own-brand to ~20% of revenue at 45–60% gross margin drives the 14%→18% EBITDA-margin expansion at the heart of the plan.
- Recurring, high-quality revenue: Subscriptions, loyalty and B2B create predictable, higher-value cash flows that both lenders and equity investors reward.
- Capital-efficient, self-funding growth: Strong operating cash flow substantially self-funds the store rollout, keeping the business in a net-cash position and enabling early distributions.
- Differentiated, defensible positioning: The curated-advisory-plus-private-label position is structurally hard for mass pharmacy or niche stores to replicate.
14.2 What to underwrite
Key findingThe honest investment summary
Wellspring is a credible, capital-efficient wellness platform with a defensible strategy and a conservative capital structure. The two adjustments a disciplined investor must make to the sponsor materials are: (1) underwrite net profit on the re-derived basis (R37m–R116m, thin early and strengthening), since the sponsor case defines EBITDA but not earnings; and (2) read leverage through a rent-inclusive lens (lease-adjusted ~2.0x, FCCR 1.99x minimum) rather than the flattering gross debt/EBITDA.
With those adjustments made, the equity case still delivers a ~20% base-case IRR (~19% with no re-rating), and the debt is comfortably serviceable on a fixed-charge basis. Notably, the business needs far less external capital than its headline programme implies, a favourable, not adverse, diligence outcome.
14.3 Valuation benchmarking
The entry valuation of ~7.5x EV/EBITDA is conservative relative to where scaled, branded, private-label-rich retail typically transacts. Specialty and health-and-wellness retailers with defensible brands and recurring revenue have historically changed hands in the 8x–12x EV/EBITDA range, with private-label-rich and digitally-enabled models toward the upper end. WWG’s combination of curation, private-label economics and subscription revenue supports a re-rating case, though the base return is not dependent on it.
|
Reference point |
Typical EV/EBITDA |
|---|---|
|
General retail |
5.0x – 7.0x |
|
Specialty / health & wellness retail |
8.0x – 12.0x |
|
Private-label-rich / digital retail |
10.0x – 14.0x |
|
Wellspring — entry |
~7.5x |
|
Wellspring — base-case exit |
8.0x |
Table 14.1 Indicative valuation benchmarks (illustrative ranges; not a substitute for a formal comparable-company analysis).
Analyst flagBenchmarks are indicative, not a valuation
The ranges above are directional context, not a formal valuation. Actual multiples depend on scale, growth durability, margin quality, recurring-revenue share, governance and market conditions. A prospective investor should commission an independent comparable-company and precedent-transaction analysis. The plan’s returns are structured to be attractive even at the conservative end of these ranges.
14.4 Conclusion
Wellspring Wellness Group is strategically positioned to evolve from a specialty wellness retailer into a fully integrated wellness ecosystem, combining curated retail, scalable digital commerce, high-margin private label and advisory services. Through disciplined execution across private-label expansion, omnichannel integration, recurring-revenue monetisation and eventual regional growth, the business is capable of delivering sustained double-digit revenue growth, structural margin expansion and strong cash conversion.
The R150m raise funds a coherent, sequenced programme with clear milestones and dependencies, right-sized to genuine external need. The independent re-underwriting in this Document confirms that, even on conservative earnings assumptions and a rent-inclusive credit lens, the plan is both bankable for lenders and attractive for equity investors. Management welcomes engagement, diligence and partnership to deliver it.
StrengthHeadline terms
Capital sought: R150m (R90m equity / R60m senior debt)
Indicative equity: ~11.4% for R90m at ~7.5x EV/EBITDA
Base-case returns: ~20% IRR / 2.4x MOIC over five years
Credit profile: FCCR 1.99x min, net-cash throughout, R15m DSRA